Outcome of five years of accelerated surveillance in patients at high risk for inherited breast/ovarian cancer: Report of a phase II trial

Military Medicine

Volumn 169, Issue 6, 2004, Pages 411-416

  Fries, Melissa H ^a   Hailey, B Jo ^a   Flanagan, Judith ^a   Licklider, Diane ^a  

^a USAF Medical Center Keesler   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER RISK; CONTROLLED STUDY; DISEASE COURSE; DISTRESS SYNDROME; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; HIGH RISK PATIENT; HUMAN; IMAGING SYSTEM; INTERVIEW; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONCOGENE; OSTEOPOROSIS; OUTCOMES RESEARCH; OVARY CANCER; PHYSICAL EXAMINATION; PSYCHOLOGIST; PSYCHOMETRY; SEXUAL FUNCTION; STATISTICAL SIGNIFICANCE; BREAST TUMOR; CLINICAL TRIAL; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; HEALTH CARE; HEALTH SURVEY; MIDDLE AGED; OVARY TUMOR; PHASE 2 CLINICAL TRIAL; PUBLIC HOSPITAL; RISK FACTOR; TIME; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BREAST NEOPLASMS; COMPREHENSIVE HEALTH CARE; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC SCREENING; HOSPITALS, MILITARY; HUMANS; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; POPULATION SURVEILLANCE; RISK FACTORS; TIME FACTORS;

EID: 4344594422     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.169.6.411     Document Type: Article

References (21)

1. Rowell S, Newman B, Boyd J, King M-C: Inherited predisposition to breast and ovarian cancer. Am J Hum Genet 1994; 55: 861-5.
2. Easton DF, Bishop DT, Ford D, Crockfor GP, Breast Cancer Linkage Consortium: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52: 678-701.
3. Struewing JP, Harge P, Wacholder S, et al: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 36: 1401-8.
4. Antoniou A, Pharoah PDP, Narod S, Risch HA, et al: Average risks of breast and ovarian cancer associated with BRCa1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003; 72.
5. Friedman LS, Gayther, Kurosaki T, et al: Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 1997; 60: 313-9.
6. Whittemore AS, Gong G, Itnyre J: Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet 1997; 60: 496-504.
7. Fries MH, et al: Diagnostic criteria for testing for BRCA1 and 2: the experience of the DOD Familial Breast/Ovarian Cancer Research Project. Milit Med 2002; 167: 99-103.
8. Fries MH, et al: Guidelines for evaluation of patients at risk for inherited breast and ovarian cancer. Milit Med 2002; 167: 93-8.
9. Couch FJ, DeShano ML, Blackwood MA, et al: BRCA 1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997; 336: 1409-15.
10. Frank TS, Deffenbaugh AM, Reid JE, Hulik M, Ward BE, et al: Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clinical Oncol 2002; 20: 1480-90.
11. Thomson D, Easton DF, Breast Cancer Linkage Consortium: Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002; 94: 1358-65.
12. Hemminki A, et al: A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998; 391: 184-7.
13. Meijers-Heijboer H, et al: Breast cancer after prophylactic bilateral mastectomy in women with a BRCA 1 or BRCA 2 mutation. N Engl J Med 2001; 345: 159-64.
14. Kauff NA, et al: Risk reducing salpingo-oophorectomy in women with a BRCA1 or BRCA 2 mutation. N Engl J Med 2002; 346: 1609-15.
15. Meijers-Heijboer H, Brekelmans CTM, Menke-Pluymers M, Seynaeve C, Baalbergen A, et al: Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 2003; 21: 1675-81.
16. Cohen L, Fishman DA: Ultrasound and ovarian cancer. Cancer Treat Res 2002; 107: 119-32.
17. Modugno F, Weissfeld JL, Hill LM: Reproducibility in the assessment of postmenopausal ovaries with transvaginal ultrasound. Gynecol Oncol 2000; 77: 289-92.
18. Burk VK, Stein K: Epidemiology of depression throughout the female life cycle. J Clin Psychiatry 2002; 63(Suppl 7): 9-15.
19. Minicuci N, Maggi S, Pavan M, Enzi G, Crepaldi G: Prevalence rate and correlates of depressive symptoms in older individuals: the Veneto Study. J Gerontol A Biol Sci Med Sci 2002; 57: 155-61.
20. Keller MB, Hanks DL: The natural history and heterogeneity of depressive disorders: implications for rational antidepressant therapy. J Clin Psychiatry 1994; 55(Suppl A): 25-31.
21. Bosworth HB, Bastian LA, Kuchibhatla MN, Steffens DC, et al: Depressive symptoms, menopausal status, and climacteric symptoms at midlife. Psychosom Med 2001; 63: 603-8.